Q32 Historical Income Statement

QTTB Stock   24.55  2.49  9.21%   
Historical analysis of Q32 Bio income statement accounts such as Cost Of Revenue of 549.1 K, Total Operating Expenses of 69.8 M, Total Other Income Expense Net of 5.3 M or Income Tax Expense of 27.2 M can show how well Q32 Bio performed in making a profits. Evaluating Q32 Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Q32 Bio's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Q32 Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Q32 Bio is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Q32 Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.

About Q32 Income Statement Analysis

Q32 Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Q32 Bio shareholders. The income statement also shows Q32 investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Q32 Bio Income Statement Chart

At present, Q32 Bio's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 27.2 M, whereas Depreciation And Amortization is forecasted to decline to about 549.1 K.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Q32 Bio. It is also known as Q32 Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Q32 Bio income statement and represents the costs associated with goods and services Q32 Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Q32 Bio financial statement analysis. It represents the amount of money remaining after all of Q32 Bio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Q32 Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Q32 Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Q32 Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.At present, Q32 Bio's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 27.2 M, whereas Depreciation And Amortization is forecasted to decline to about 549.1 K.
 2022 2023 2024 (projected)
Total Operating Expenses45.9M92.7M69.8M
Cost Of Revenue2.6M578K549.1K

Q32 Bio income statement Correlations

0.710.6-0.56-0.770.65-0.740.850.6-0.58-0.12-0.5-0.190.530.14-0.140.05-0.13
0.710.11-0.09-0.430.14-0.40.620.12-0.11-0.28-0.08-0.110.930.06-0.06-0.01-0.05
0.60.11-0.99-0.931.0-0.940.661.0-0.990.4-0.970.37-0.22-0.330.35-0.160.33
-0.56-0.09-0.990.94-0.980.95-0.6-0.991.0-0.460.99-0.480.240.39-0.380.19-0.34
-0.77-0.43-0.930.94-0.941.0-0.75-0.930.94-0.320.92-0.39-0.120.3-0.30.14-0.27
0.650.141.0-0.98-0.94-0.940.70.99-0.990.38-0.960.33-0.19-0.30.31-0.170.29
-0.74-0.4-0.940.951.0-0.94-0.73-0.940.95-0.350.94-0.43-0.080.33-0.320.16-0.29
0.850.620.66-0.6-0.750.7-0.730.66-0.610.12-0.52-0.230.370.21-0.210.13-0.19
0.60.121.0-0.99-0.930.99-0.940.66-0.990.4-0.970.39-0.21-0.350.38-0.180.35
-0.58-0.11-0.991.00.94-0.990.95-0.61-0.99-0.410.99-0.460.220.39-0.380.22-0.35
-0.12-0.280.4-0.46-0.320.38-0.350.120.4-0.41-0.460.5-0.43-0.040.060.35-0.03
-0.5-0.08-0.970.990.92-0.960.94-0.52-0.970.99-0.46-0.580.240.49-0.490.25-0.45
-0.19-0.110.37-0.48-0.390.33-0.43-0.230.39-0.460.5-0.58-0.26-0.790.77-0.370.7
0.530.93-0.220.24-0.12-0.19-0.080.37-0.210.22-0.430.24-0.260.22-0.220.11-0.2
0.140.06-0.330.390.3-0.30.330.21-0.350.39-0.040.49-0.790.22-0.960.84-0.95
-0.14-0.060.35-0.38-0.30.31-0.32-0.210.38-0.380.06-0.490.77-0.22-0.96-0.710.99
0.05-0.01-0.160.190.14-0.170.160.13-0.180.220.350.25-0.370.110.84-0.71-0.77
-0.13-0.050.33-0.34-0.270.29-0.29-0.190.35-0.35-0.03-0.450.7-0.2-0.950.99-0.77
Click cells to compare fundamentals

Q32 Bio Account Relationship Matchups

Q32 Bio income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization6.3M8.9M9.5M2.6M578K549.1K
Gross Profit1.7M2.7M24.4M4.1M578K549.1K
Other Operating Expenses111.6M133.0M36.7M45.9M93.3M72.2M
Operating Income(109.9M)(130.3M)(36.7M)(39.2M)(92.1M)(96.7M)
Ebit(109.9M)(130.3M)(95.8M)(41.5M)(87.1M)(91.4M)
Research Development89.4M100.4M29.9M35.8M62.0M54.0M
Ebitda(103.6M)(121.4M)(86.2M)(38.9M)(86.5M)(90.8M)
Total Operating Expenses105.3M124.1M36.7M45.9M92.7M69.8M
Income Before Tax(103.9M)(128.7M)(37.0M)(42.7M)(87.1M)(91.4M)
Total Other Income Expense Net6.0M1.6M(324K)(3.5M)5.0M5.3M
Net Income(103.9M)(128.7M)(37.6M)(42.8M)(113.0M)(107.3M)
Total Revenue1.7M2.7M34.0M6.7M1.2M1.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Q32 Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Q32 Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Q32 Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Q32 Bio Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Q32 Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.50)
Revenue Per Share
(1.24)
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Q32 Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.